Capstan Therapeutics

San Diego, United States

Capstan Therapeutics develops in vivo mRNA and gene-editing medicines for a broad range of diseases.

Mar 2024

Series B

Biotechnology Health Care Medical Therapeutics

Top Investors

RA Capital ManagementPerceptive AdvisorsVida VenturesPolaris PartnersOrbiMed

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Capstan Therapeutics

Who are Capstan Therapeutics's investors?

Capstan Therapeutics's investors include RA Capital Management, Perceptive Advisors, Vida Ventures, Polaris Partners, OrbiMed.

Where is Capstan Therapeutics headquartered?

Capstan Therapeutics is headquartered in San Diego, United States.

What does Capstan Therapeutics do?

Capstan Therapeutics develops in vivo mRNA and gene-editing medicines for a broad range of diseases.

What stage is Capstan Therapeutics at?

Capstan Therapeutics is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 20, 2024.

MLA

"Capstan Therapeutics — Funding & Investors." VCBacked, March 20, 2024, https://www.vcbacked.co/company/capstan-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2024). Capstan Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/capstan-therapeutics

Wikipedia (cite web)

{{cite web |title=Capstan Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/capstan-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 20, 2024.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver

Rapport Therapeutics

Boston

Neuroglee Therapeutics

Singapore

Living In Silico Inc.